logo
#

Latest news with #PfizerCanada

Pfizer Canada and HPIC Mark 30 Years of Humanitarian Partnership Delivering Global Health Impact Français
Pfizer Canada and HPIC Mark 30 Years of Humanitarian Partnership Delivering Global Health Impact Français

Cision Canada

time3 hours ago

  • Health
  • Cision Canada

Pfizer Canada and HPIC Mark 30 Years of Humanitarian Partnership Delivering Global Health Impact Français

KIRKLAND, QC, Aug. 19, 2025 /CNW/ - On World Humanitarian Day, Pfizer Canada is proud to mark 30 years of partnership with Health Partners International of Canada (HPIC), a collaboration that has delivered over $70 million worth of life-saving medicines to vulnerable communities across 58 countries. Since 1995, Pfizer Canada has supported HPIC's mission to increase access to medicine and improve health outcomes in underserved regions around the world. Through more than 620 donations over three decades, Pfizer has helped equip medical missions, stock clinics, and mobilize emergency relief efforts. The partnership has supported 161 Canadian Non-Governmental Organizations (NGOs) and contributed to HPIC's three core program areas: Access to Medicine, Emergency Response, and Women and Children's Health. "We are incredibly proud of our long-standing partnership with HPIC," said Vincent Lamoureux, Director, Global Health Investments, Pfizer. "Supporting their work is not just a privilege—it's our responsibility. Their dedication to improving global health aligns deeply with our purpose, and we remain committed to helping expand their reach and impact." HPIC's model is built on collaboration. Medicines donated by Pfizer and other pharmaceutical partners are securely packed at HPIC's Distribution Centre into Humanitarian Medical Kits or bulk shipments. These are then delivered to communities in need, often in partnership with local NGOs, clinics, and volunteer medical teams. "Meaningful and collective partnerships are the essence of why HPIC can provide dignified healthcare services and essential medicines to people living in poverty, victims of conflict or war, or of a natural disaster," said Lois Brown, President of HPIC. "We deeply value our long-standing partnership with Pfizer Canada, whose support is integral to our everyday operations and mission." As global health challenges continue to persist, Pfizer Canada remains committed to supporting HPIC's mission and expanding access to care for those who need it most. To learn more about HPIC and how you can support their work, visit About HPIC Health Partners International of Canada (HPIC) is a Canadian charitable humanitarian organization dedicated to increasing access to medicine and improving health in vulnerable communities around the world, and the only charity in Canada licensed by Health Canada to handle donated medicines. Since 1990, HPIC has delivered over $735 million in donated medicines and related supplies together with its partner organizations in over 130 countries. By equipping medical mission teams, stocking clinics and hospitals in remote or impoverished communities, mobilizing medical relief during emergencies and building local capacity, Health Partners International of Canada has enabled over 35 million vulnerable people to access life-transforming healthcare and hope for a brighter future. About Pfizer Canada Pfizer Canada ULC is the Canadian operation of Pfizer Inc., one of the world's leading biopharmaceutical companies. At Pfizer, we apply science and our global resources to bring therapies to people that help extend and improve their lives. We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products. Every day, Pfizer colleagues work to advance wellness, prevention, treatments, and cures that challenge the most feared diseases of our time. To learn more about Pfizer Canada, visit or you can follow us on LinkedIn, Facebook, X, Instagram or YouTube.

Pfizer Canada, BioNTech get Health Canada approval for COVID variant vaccine
Pfizer Canada, BioNTech get Health Canada approval for COVID variant vaccine

Business Insider

time12 hours ago

  • Health
  • Business Insider

Pfizer Canada, BioNTech get Health Canada approval for COVID variant vaccine

Pfizer Canada (PFE) and BioNTech (BNTX) announced that Health Canada has authorized the LP.8.1 variant adapted COMIRNATY COVID-19 vaccine for individuals aged 6 months and older. The updated COMIRNATY vaccine targets the Omicron LP.8.1 variant, one of the most recently circulating SARS-CoV-2 lineages. This season's Pfizer and BioNTech COVID-19 vaccine will be available in pharmacies across the country in the fall. The public program operates according to the eligibility criteria determined by each province. If an individual meets these criteria, they will be eligible to receive the vaccine for free. Efforts are ongoing in collaboration with private insurers and payers to streamline reimbursement processes within the private sector, for those who do not meet public program requirements. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Uniting for Migraine Awareness: Second Year of Out of Office for Migraine Awareness Educates Canadian Workplaces Français
Uniting for Migraine Awareness: Second Year of Out of Office for Migraine Awareness Educates Canadian Workplaces Français

Cision Canada

time09-06-2025

  • Health
  • Cision Canada

Uniting for Migraine Awareness: Second Year of Out of Office for Migraine Awareness Educates Canadian Workplaces Français

An estimated 25% of Canadian employees report living with migraine, yet only 12% receive a diagnosis from healthcare professionals i Limited education and employee resources continues to result in stigma related to migraine in the workplace, significantly impacting employee performance and well-being ii KIRKLAND, QC, June 9, 2025 /CNW/ - Pfizer Canada, in partnership with Migraine Canada and Migraine Quebec, is reintroducing the Out of Office for Migraine Awareness campaign for Migraine Awareness Month in June. In its second year, the campaign continues to raise awareness of the impact of migraine and empower Canadians to foster more supportive work environments for those living this debilitating neurological condition that deeply impacts professional and personal life. iii During Migraine Awareness Month, Canadian organizations, employers, and employees are encouraged to use their Out of Office (OOO) Alert for four hours – the minimum duration of an average migraine – to show solidarity with colleagues living with migraine (example below). iv,v "Migraine is widely misunderstood in the workplace and ultimately leads employees to 'push through,' despite it reducing productivity and potentially leading to burnout," says Debby Carreau, CEO and Founder, inspiredHR, a HR consultancy firm. "By understanding what migraine is, colleagues can support those living with the condition by reducing the stigma associated with taking time off work due to migraine attacks." Migraine prevalence peaks during prime working years, and statistics suggest that a substantial portion of the workforce is affected by it. vi Migraine management resources equip organizations to help their employees better understand absenteeism and presenteeism (i.e. when employees are not fully functioning in the workplace because of an illness). i "Migraine can be physically and mentally debilitating for millions of Canadians, often going unnoticed by peers," says Wendy Gerhart, Executive Director, Migraine Canada. "The OOO Alert is a simple step that colleagues can share to show compassion and ignite more meaningful dialogue around migraine in the workplace. We encourage Canadians to tap into available resources, replacing stigma and skepticism with support." About Migraine in the Workplace More than five million Canadians live with migraine. ii While migraine affects all demographics, its prevalence peaks for people in their 30s and 40s, when most individuals are likely employed. vi Despite this, migraine remains highly misunderstood and stigmatized in the workplace as being directly related to one's ability to work. vii "The implication of migraine costs the Canadian economy many billions of dollars each year ii with costs related to missed workdays alone being at 980 million dollars per year," ii ,viii says Dr. Will Kingston, Neurologist, Sunnybrook Hospital, Toronto. "Despite this, migraine remains underdiagnosed due to a lack of education and training on where to access resources for support, leading to profound impact on work performance and wellbeing." ii "At Pfizer Canada we're committed to supporting migraine patients as well as educating our communities," said Ranjita Banerjee, Primary Care Portfolio Lead, Pfizer Canada."Leveraging an OOO Alert is the perfect conversation starter, at the office or virtually, to help colleagues better support one another. We're excited to see how this campaign evolves in its second year to spread the word about migraine." As pictured below, the OOO Alert message can provide key migraine information, statistics, and resources to show allyship for colleagues impacted by migraine while encouraging their professional network to learn more. Additional Quotes "Migraine can be trivialized both in professional environments and in day-to-day life. We work hard to provide resources to those who experience it, as well as those in their personal and professional circles, so they can gain a deeper knowledge of the condition, its possible treatments, and the potential accommodations that can help sustain employment amidst the challenges," says Véronique Clément, Executive Director, Migraine Québec. "This campaign, and the small step of turning on an OOO Alert, is a great opportunity for employers in particular to support their colleagues who may feel limited and isolated in the workplace." "Migraine is a chronic disease ix without a definitive cure, yet with proper management especially in the workplace, the impact can be significantly reduced," said Dr. Heather Pim, associate clinical professor of neurology, University of Montreal, director of the Headache Clinic at the University of Montreal Hospital Centre, and president of Migraine Québec. "I'm proud to be a part of this campaign as it promotes a healthier and more inclusive workplace practice in service to the overall health of patients." For more information on migraine, please visit or About Migraine Canada Migraine Canada is a nationally-registered charity organization dedicated to improving the lives of all Canadians living with migraine and other headache disorders. Our vision is to see that all Canadians living with migraine and headache disorders are diagnosed, treated and supported so their quality of life is optimized. Visit About Migraine Québec Migraine Quebec is a charity organization founded in 2014. Its mission is to enhance the quality of life of people living with migraine throughout Québec. Their vision is to help build a society where people living with migraine can thrive, without limitations or stigmatization. Visit About Pfizer Canada Pfizer Canada ULC is the Canadian operation of Pfizer Inc., one of the world's leading biopharmaceutical companies. At Pfizer, we apply science and our global resources to bring therapies to people that help extend and improve their lives. We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products. Every day, Pfizer colleagues work to advance wellness, prevention, treatments, and cures that challenge the most feared diseases of our time. To learn more about Pfizer Canada, visit or you can follow us on LinkedIn, Facebook, X, Instagram or YouTube.

Uniting for Migraine Awareness: Second Year of Out of Office for Migraine Awareness Educates Canadian Workplaces
Uniting for Migraine Awareness: Second Year of Out of Office for Migraine Awareness Educates Canadian Workplaces

Yahoo

time09-06-2025

  • Health
  • Yahoo

Uniting for Migraine Awareness: Second Year of Out of Office for Migraine Awareness Educates Canadian Workplaces

An estimated 25% of Canadian employees report living with migraine, yet only 12% receive a diagnosis from healthcare professionalsi Limited education and employee resources continues to result in stigma related to migraine in the workplace, significantly impacting employee performance and well-beingii KIRKLAND, QC, June 9, 2025 /CNW/ - Pfizer Canada, in partnership with Migraine Canada and Migraine Quebec, is reintroducing the Out of Office for Migraine Awareness campaign for Migraine Awareness Month in June. In its second year, the campaign continues to raise awareness of the impact of migraine and empower Canadians to foster more supportive work environments for those living this debilitating neurological condition that deeply impacts professional and personal During Migraine Awareness Month, Canadian organizations, employers, and employees are encouraged to use their Out of Office (OOO) Alert for four hours – the minimum duration of an average migraine – to show solidarity with colleagues living with migraine (example below).iv,v "Migraine is widely misunderstood in the workplace and ultimately leads employees to 'push through,' despite it reducing productivity and potentially leading to burnout," says Debby Carreau, CEO and Founder, inspiredHR, a HR consultancy firm. "By understanding what migraine is, colleagues can support those living with the condition by reducing the stigma associated with taking time off work due to migraine attacks." Migraine prevalence peaks during prime working years, and statistics suggest that a substantial portion of the workforce is affected by Migraine management resources equip organizations to help their employees better understand absenteeism and presenteeism (i.e. when employees are not fully functioning in the workplace because of an illness).i "Migraine can be physically and mentally debilitating for millions of Canadians, often going unnoticed by peers," says Wendy Gerhart, Executive Director, Migraine Canada. "The OOO Alert is a simple step that colleagues can share to show compassion and ignite more meaningful dialogue around migraine in the workplace. We encourage Canadians to tap into available resources, replacing stigma and skepticism with support." About Migraine in the Workplace More than five million Canadians live with While migraine affects all demographics, its prevalence peaks for people in their 30s and 40s, when most individuals are likely Despite this, migraine remains highly misunderstood and stigmatized in the workplace as being directly related to one's ability to work. vii "The implication of migraine costs the Canadian economy many billions of dollars each yearii with costs related to missed workdays alone being at 980 million dollars per year," ii ,viii says Dr. Will Kingston, Neurologist, Sunnybrook Hospital, Toronto. "Despite this, migraine remains underdiagnosed due to a lack of education and training on where to access resources for support, leading to profound impact on work performance and wellbeing." ii "At Pfizer Canada we're committed to supporting migraine patients as well as educating our communities," said Ranjita Banerjee, Primary Care Portfolio Lead, Pfizer Canada. "Leveraging an OOO Alert is the perfect conversation starter, at the office or virtually, to help colleagues better support one another. We're excited to see how this campaign evolves in its second year to spread the word about migraine." As pictured below, the OOO Alert message can provide key migraine information, statistics, and resources to show allyship for colleagues impacted by migraine while encouraging their professional network to learn more. Additional Quotes "Migraine can be trivialized both in professional environments and in day-to-day life. We work hard to provide resources to those who experience it, as well as those in their personal and professional circles, so they can gain a deeper knowledge of the condition, its possible treatments, and the potential accommodations that can help sustain employment amidst the challenges," says Véronique Clément, Executive Director, Migraine Québec. "This campaign, and the small step of turning on an OOO Alert, is a great opportunity for employers in particular to support their colleagues who may feel limited and isolated in the workplace." "Migraine is a chronic diseaseix without a definitive cure, yet with proper management especially in the workplace, the impact can be significantly reduced," said Dr. Heather Pim, associate clinical professor of neurology, University of Montreal, director of the Headache Clinic at the University of Montreal Hospital Centre, and president of Migraine Québec. "I'm proud to be a part of this campaign as it promotes a healthier and more inclusive workplace practice in service to the overall health of patients." For more information on migraine, please visit or About Migraine Canada Migraine Canada is a nationally-registered charity organization dedicated to improving the lives of all Canadians living with migraine and other headache disorders. Our vision is to see that all Canadians living with migraine and headache disorders are diagnosed, treated and supported so their quality of life is optimized. Visit About Migraine Québec Migraine Quebec is a charity organization founded in 2014. Its mission is to enhance the quality of life of people living with migraine throughout Québec. Their vision is to help build a society where people living with migraine can thrive, without limitations or stigmatization. Visit About Pfizer Canada Pfizer Canada ULC is the Canadian operation of Pfizer Inc., one of the world's leading biopharmaceutical companies. At Pfizer, we apply science and our global resources to bring therapies to people that help extend and improve their lives. We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products. Every day, Pfizer colleagues work to advance wellness, prevention, treatments, and cures that challenge the most feared diseases of our time. To learn more about Pfizer Canada, visit or you can follow us on LinkedIn, Facebook, X, Instagram or YouTube. References: _____________________________ i Migraine Canada. Work and Disability. Accessed May 2025 at ii Migraine Canada. Access to Care and Treatment for Migraine in Canada Report Card. Accessed May 2025 at iii Patenaude, J., Gouault Laliberté, A., Beauchemin, C. and Lachaine, J. June 2023. PCR72 The Impact of Migraine on Canadians' Productivity: A Real-World Pharmacy-Based Study. Value in Health, 26 (6). Abstract: iv American Migraine Foundation. How Long Does A Migraine Attack Last. Accessed April 2025 at v Cleveland Clinic. Migraine Headaches. Accessed April 2025 at vi Ramage-Morin PL, Gilmour H. Prevalence of migraine in the Canadian household population. Health Rep. 2014 Jun;25(6):10-6. PMID: 24941316. vii Young, W. B., Park, J. E., Tian, I. X., & Kempner, J. (2013). The stigma of migraine. PloS one, 8(1). DOI: viii Zhang W, McLeod C, Koehoorn M. The relationship between chronic conditions and absenteeism and associated costs in Canada. Scandinavian Journal of Work, Environment & Health. 2016; 42: 413422. ix NIH Medline Plus. When migraine turns chronic. Accessed May 2025 at SOURCE Pfizer Canada Inc. View original content to download multimedia:

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store